Terrence J Bradley, Md

This study tests an experimental drug called IMG-7289 in people with two rare blood cancers—essential thrombocythemia (ET) and polycythemia vera (PV)—whose disease did not get better with or could not tolerate standard treatments. The goal is to see if the drug can help control b…